Charles Stout, MD
Clinical Cardiac Electrophysiology · Pueblo, CONPI 1497756597
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,455 of the $8,808 with a category attached, or 84.6%. Boston Scientific accounts for 64.2% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2019 at $2,537 and has fallen 78.6% since, to $544 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in CO, where the typical reported total is $11,587.
Across 199 payments — averaging $44.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$6K
- Medtronic$1K
- Abbott$656
- Sanofi-aventis U.S. LLC$302
- Cardiva Medical, Inc.$150
- E.r. Squibb & Sons, L.L.C.$148
- plus $742 from 13 others
What the payments were for
- Travel & lodging$1,35215%
- Food & beverage$7,45585%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 112 | $5,657 |
| Medtronic(2 entities) | 28 | $1,153 |
| Abbott | 15 | $656 |
| Sanofi-aventis U.S. LLC | 3 | $302 |
| Cardiva Medical, Inc. | 5 | $150 |
| E.r. Squibb & Sons, L.L.C. | 9 | $148 |
| Johnson & Johnson(2 entities) | 4 | $130 |
| Acutus Medical, Inc. | 1 | $119 |
| Biosense Webster, Inc. | 3 | $108 |
| Pfizer | 4 | $78 |
| Novartis | 3 | $67 |
| Atricure, Inc. | 1 | $48 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $44 |
| Boehringer Ingelheim | 2 | $34 |
| Amgen | 2 | $30 |
| Abiomed | 1 | $29 |
| Alnylam Pharmaceuticals Inc. | 1 | $27 |
| Merck | 1 | $15 |
| Kestra Medical Technology Services, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Watchman$1,496
- GENERAL - THERAPIES$631
- Rhythmia Mapping System$426
- Reveal LINQ$392
- GENERAL TACHY$266
- MULTAQ$208
- ENSITE$134
- WATCHMAN Access System$122
- LINQ II$119
- Ensite Cardiac Mapping System$113
- AMPLATZER Occluders$113
- WATCHMAN FLX$112
- RHYTHMIA$102
How this compares
$8,808 in reported general payments places this provider in the 40th percentile of 66 clinical cardiac electrophysiology providers in Colorado.
See all clinical cardiac electrophysiology providers in Colorado →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 587 | $765,315 |
| XareltoRivaroxaban | 164 | $168,251 |
| EntrestoSacubitril/Valsartan | 49 | $72,210 |
| JardianceEmpagliflozin | 12 | $21,240 |
| FarxigaDapagliflozin Propanediol | 15 | $14,562 |
| Flecainide Acetate | 285 | $13,986 |
| Metoprolol Succinate | 441 | $6,379 |
| PradaxaDabigatran Etexilate Mesylate | 18 | $4,425 |
| SotalolSotalol Hcl | 118 | $2,540 |
| Digoxin | 67 | $2,301 |
| Amiodarone Hcl | 39 | $1,699 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 42 | $1,273 |
| Spironolactone | 129 | $1,124 |
| Carvedilol | 112 | $1,080 |
| Losartan Potassium | 111 | $1,019 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $78 | $765,315587 claims |
| Johnson & JohnsonXarelto | $130 | $168,251164 claims |
| NovartisEntresto | $67 | $72,21049 claims |
| Boehringer IngelheimJardiance, Pradaxa | $34 | $25,66430 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 66 clinical cardiac electrophysiology providers in Colorado.
Other clinical cardiac electrophysiology in Pueblo
- Kathleen BrownPueblo$67K
- Srikanth SundaramLittleton$493K
- Bradley MikaelianColorado Springs$364K
- Wendy TzouAurora$350K
- Christopher PorterfieldAurora$340K
- Lohit GargAurora$147K
- Ethan EllisFort Collins$144K
- Ganesh VenkataramanLakewood$127K
- Margot VlokaAurora$104K
- Benjamin SteinbergDenver$98K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.